Search results for: Health Policy and Regulation
Filter search results
Competition through Innovation, Innovation through Competition
1 November 1998
…pharmaceutical industry’s output could instead be promoted by enhancing demand side pressures (informed payers and incentivised prescribers can get value for money) and by ensuring high rewards for breakthrough innovations….
OHE Critique of CBO’S Pharmaceutical Investment Model Provides Warning for Policymakers on Reliability of Estimates
3 December 2021
…Policymakers should clearly understand that the CBO’s estimates are subject to considerable uncertainty and should exercise caution in relying on these findings for evaluating the potential impact of real-world policy…
What is a life worth in climate policy? It depends on who you ask
22 July 2026
…the methods that have been applied to value these health impacts and found big discrepancies. Part of the problem is that health economists and environmental economists value the same avoided…
New NICE Manual for Health Technology Evaluations: A Critical Discussion on the Most Relevant Changes (or Lack Thereof)
23 February 2022
…and advice for health, public health, and social care practitioners. In England and Wales, new health technologies are appraised based on NICE guidance to determine whether they should be made…
Towards a New Understanding of Unmet Medical Need
22 June 2021
…and stakeholder perceptions. Value Health. 2019; 22:1275–82. https://doi.org/10.1016/j.jval.2019.07.007 Zhang, K., Kumar, G. & Skedgel, C. Towards a New Understanding of Unmet Medical Need. Appl Health Econ Health Policy (2021). https://doi.org/10.1007/s40258-021-00655-3…
Unpacking the Black Box of Payer Policy: A Demand-Side Approach for Equitable Uptake of Cost-Effective Health Innovation
21 February 2020
…a transition from external health assistance, and donors unlikely to expand or even maintain existing push initiatives, this suggests a grim outlook for future global health innovation and uptake. Recent CGD analysis suggests that governments are…
Spotlight on OHE: Innovation, Regulation and Antibiotics
30 September 2014
…research and analyses on innovation and antibiotics are available by clicking here. Understanding the connection between regulation and innovation The Regulatory Policy Institute, based in Oxford, holds an annual conference…
Funding Challenges in the Malaysian Health Care System
7 January 2020
Adrian Towse presented at the Monash Malaysia Health Economics Forum 2019 on three related topics: health system financing in Malaysia; pharmaceutical price regulation and competition in Malaysia; and the potential…
Innovation for Health System Efficiency and Improvement
20 November 2023
…(e.g. technology barriers) 2) the health system’s ability to fund or integrate the innovation, and 3) the clinicians’ and patients’ readiness and willingness to engage with the innovation. Overcoming barriers…